ABOUT VHIO

VHIO is a leading comprehensive cancer center of excellence where its scientists and physicians adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer:

DISCOVER MORE

PROGRAMS & GROUPS

Scientific activity at VHIO is structured across for major programs: Preclinical, Translational, Clinical Research, and Core Technologies. Each incorporates research teams of excellence dedicated to harnessing and rapidly translating discoveries into tangible benefits for patients.

MEET VHIO´S TEAMS

NEWS

A COLOSSUS multi-center undertaking aimed at better classifying and treating metastatic colorectal cancer

14/02/2018|Comments Off on A COLOSSUS multi-center undertaking aimed at better classifying and treating metastatic colorectal cancer

Oncology channel ecancer catches up with VHIO’s Joaquin Mateo on the ground at ASCO’s Genitourinary Cancer Symposium

12/02/2018|Comments Off on Oncology channel ecancer catches up with VHIO’s Joaquin Mateo on the ground at ASCO’s Genitourinary Cancer Symposium

Genetic gene mutations: opening new therapeutic avenues in metastatic prostate cancer

08/02/2018|Comments Off on Genetic gene mutations: opening new therapeutic avenues in metastatic prostate cancer

Guts, Bugs, Cells and beating gastrointestinal cancer: VHIO shortlisted for Cancer Research UK’s Grand Challenge

08/02/2018|Comments Off on Guts, Bugs, Cells and beating gastrointestinal cancer: VHIO shortlisted for Cancer Research UK’s Grand Challenge

See all news

DIRECTION &
PRINCIPAL INVESTIGATORS

Research at VHIO is led by our Director, Josep Tabernero, and supported by a consultative body, VHIO´s Scientific Committee headed by José Baselga. A total of 25 renowned Principal Investigators manage and run VHIO´s major research themes and programs.

BROWSE OUR PIs
Launch our Scientific Report 2016

CLINICAL TRIALS

Driving drug development & targeted therapies against cancer, VHIO has become a leading reference in drug discovery from concept to clinic:

CLINICAL TRIALS OFFICE
RESEARCH UNIT FOR MOLECULAR THERAPY OF CANCER – “LA CAIXA”
CURRENTLY OPEN TRIALS

PROJECTS

Research at VHIO is made possible through the support received from private institutions, funding entities, companies and individuals, as well as International and National Competitive Grants. Find out more about our supporters, current projects and VHIO´s Scientific Coordination Area:

CURRENT PROJECTS
SCIENTIFIC COORDINATION

EVENTS

VHIO organizes international symposia of excellence as well as ad-hoc courses and workshops through which it shares its expertise and promotes debate and exchange of the highest degree:

INTERNATIONAL SYMPOSIA
WORKSHOPS & COURSES
BENCHSTORMING SEMINARS